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Abstract The 21-residue peptide KLLLLKLLLLKLL- 
LLKLLLLK (KL4) has been synthesized and analyzed regarding 
its secondary structure and orientation in lipid environments. 
Fourier transform infrared and circular dichroism spectroscopy 
shows that the peptide exhibits approximately 80% a-helical 
content both in dodecylphosphocholine micelles and in 1,2- 
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/phosphatidyl- 
glycerol (PG) 7:3 (w/w) bilayers. The positively charged lysine 
residues are evenly distributed over the entire, otherwise 
nonpolar, circumference of the helix. This is in sharp contrast 
to the uneven distribution of polar and nonpolar residues in 
amphipathic helices. Fourier transform infrared spectroscopy of 
the peptide inserted in DPPC/PG bilayers shows that the helical 
axis is oriented parallel to the lipid acyl chains. These data do not 
support a previous hypothesis that the KL4 peptide interacts with 
peripheral parts of a phospholipid monolayer and mimics the 
pulmonary surfactant protein SP-B, which is composed of several 
amphipathic ¢x-helices. KL4 accelerates the spreading of 
phospholipid mixtures at an air/water interface but does so less 
efficiently than other transmembranous helical polypeptides 
studied. 
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1. Introduction 
Low levels of pulmonary surfactant in premature infants 
cause respiratory distress yndrome (RDS) [1], which is a dis- 
ease with high morbidity and mortality (see [2]). The pulmon- 
ary surfactant system consists of several ipid and protein 
constituents combined in different morphological entities. In 
the alveolar type II cell, surfactant lipids and proteins are 
packed together in dense lamellar bodies which, in the alveoli, 
are converted to a lattice of tubular myelin bilayers. Even- 
tually tubular myelin spreads into a film of mainly 1,2-dipal- 
mitoyl-sn-glycero-3-phosphocholine (DPPC) at the alveolar 
air/liquid interface. This film is responsible for lowering the 
alveolar surface tension, thus preventing lung collapse at end- 
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expiration. Four surfactant proteins (SP)-A, -B, -C and -D 
have been described to date (see [3,4]). Efficient treatment of 
RDS is achieved by airway instillation of animal lung surfac- 
tant preparations containing lipids, predominantly DPPC, 
and small amounts (1-2 weight %) of the strictly hydrophobic 
proteins SP-B and SP-C [5]. 
SP-B, a homodimer of two 79-residue polypeptide chains 
[6,7], has an a-helical content of about 45% as shown by 
Fourier transform infrared (FTIR) [8] and circular dichroism 
(CD) spectroscopy [9]. SP-B has been proposed to contain 
four amphipathic helices interacting preferentially with super- 
ficial parts of a phospholipid bilayer [9]. SP-C is a 35-residue 
polypeptide [10] with palmitoyl groups thioester-linked to the 
cysteine residues in the N-terminal part of the molecule [6]. 
FTIR spectroscopy revealed that SP-C adopts mainly an a- 
helical conformation with its a-helix oriented parallel to the 
lipid acyl chains [11,12]. These restults are supported by those 
obtained by NMR spectroscopy showing that SP-C in mixed 
organic solvents forms a very regular a-helix between posi- 
tions 9 and 34 [13] which is perfectly suited to span a DPPC 
bilayer [14]. The small sizes of SP-B and SP-C have raised the 
possibility of producing bioactive analogues, for formulating 
synthetic peptide-containing surfactant preparations. Co- 
chrane and Revak designed a 21-residue polypeptide, KL4, 
with a repetitive sequence of leucine and lysine residues [15- 
18]. This peptide mimics the pattern of hydrophobic and hy- 
drophilic residues in SP-B and was supposed to stabilize the 
phospholipid bilayer by interactions with the lipid head- 
groups and superficial parts of the acyl chains [15]. 
We now analyze the secondary structure and orientation of 
KL4 in phospholipids. We conclude that it is a transmem- 
brane peptide with a non-amphipathic but mixed nonpolar/ 
polar surface. These features are compared to those of the 
native hydrophobic surfactant polypeptides and possible im- 
plications for structure-activity relationships are discussed. 
2. Experimental procedures 
2.1. Peptide synthesis and purification 
The KL4 peptide (KLLLLKLLLLKLLLLKLLLLK, [15]) was 
synthesized on a 0.5 mmol scale using tert-butyloxycarbonyl chemistry 
in an Applied Biosystems 430A instrument. Treatment with anisol/ 
para-thiocresollhydrogen fluoride 1:1:10 (by vol) for 1 h at --4°C 
cleaved the peptide from the resin and deprotected the lysine residues. 
After removal of protecting roups and scavengers with diethylether, 
the peptide was extracted from the resin with dichloromethane/tri- 
fluoroacetic acid (TFA) 3:1 (v/v) [19]. After evaporation of solvents 
and resolubilization i  ethanol, the peptide was purified on a C18 
column (2.2 × 25 cm, Vydac) using a linear gradient of 95% ethanol/ 
0.1% TFA in 80% methanol/0.1% TFA and a flow of 10 ml/min. This 
yielded one major peak of KL4 identified by amino acid analysis, N- 
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terminal amino acid sequence analysis and laser-desorption mass spec- 
trometry. 
The SP-C/bacteriorhodopsin hybrid peptide (SP-C/BR) 
(LRIPCCPVNLKRFYAITTLVAAIAFTLYLSLLLGY), where the 
first 12 residues are identical to porcine SP-C and the remaining 23 
residues correspond to the transmembrane part of the second helix of 
bacteriorhodopsin, was synthesized and purified as described [20]. 
Native SP-C (LRIPCCPVNLKRLLVVVVVVVLVVVVIVGALL- 
MGL with both cysteines palmitoylated [6]) was purified from porcine 
lungs [21]. 
2.2. Circular dichroism spectroscopy 
For analysis of secondary structure in phospholipid micelles, the 
KL4 peptide was solubilized in 20 mM dodecylphosphocholine 
(DPC [20]; critical micelle concentration ~ 1 mM [22])/50 mM so- 
dium phosphate buffer, pH 6.0, and diluted to 10 mM DPC in the 
same buffer, giving a final peptide concentration of about 20 p.M. CD 
spectra between 260 and 184 nm were recorded at room temperature 
with a Jasco-720 instrument using a scan speed of 20 nm/min, a 
response time of 2 s, a band width of 1.0 nm, a sensitivity of 20 
mdeg and a resolution of 2 data points/nm. The residual molar ellip- 
ticity was calculated after determination of the KL4 concentration by 
amino acid analysis and expressed in kdeg × cm2/dmol. 
2.3. Attenuated total reflection Fourier transform infrared 
(ATR-FTIR) spectroscopy 
KL4 (8 nmoles) in ethanol was added to 270 nmoles of DPPC/PG 
7:3 (w/w) in chloroform. The solvents were evaporated under nitrogen 
and solvent races were removed by keeping the residue under reduced 
pressure overnight. The peptide/lipid film was hydrated in 100 ktl of 
2 mM HEPES, pH 7.4 by vortexing at 45°C. Peptide-containing ve- 
sicles were isolated by centrifugation i  a continuous ucrose gradient 
(2-30%) at 100000 ×g for 16 h at 4°C. The location of phospholipids 
in the gradient was identified by a colorimetric test for choline (Boeh- 
ringer) and peptide-containing fractions were pooled and dialysed 
extensively against 2 mM HEPES, pH 7.4. ATR-FTIR spectra were 
recorded with a Perkin-Elmer 1720X FTIR spectrophotometer at a 
resolution of 4 cm -1 . The internal reflection element was a germanium 
plate with an aperture angle of 45 °, yielding 25 internal reflections. 
128 scan cycles were averaged for each spectrum. Films of KL4 and 
KL4 associated with DPPC/PG 7:3 (w/w) were obtained by slowly 
evaporating the sample on the germanium plate under nitrogen at 
room temperature. Hydrogen to deuterium (H/D) exchange of readily 
accessible amide protons were obtained by flushing the sample on the 
ATR plate sealed in a universal sample holder with D20-saturated 
N2. 
Fourier self-deconvolution was applied in the amide I' (the prime 
indicating that an H/D exchange has been performed) spectral region 
(1700-1600 cm -1) to reveal the different secondary structure lements. 
To quantify the percentage of each resulting band, a least square 
iterative curve-fitting was performed to fit Lorentzian line shapes to 
the unconvoluted spectrum between 1700 and 1600 cm -1. The percen- 
tage of each secondary structure component was determined from the 
Lorentzian band areas in the respective frequency region (see [12,23] 
for details). 
Additional spectra were recorded with parallel (0 °) and perpendi- 
cular (90 ° ) polarized incident light with respect o the normal to the 
ATR plate. The mean angle between the helix axis and a normal to 
the ATR plate was calculated from the dichroic ratio RATR = A90°/ 
A0 °. The %(CH2) transition at 1200 cm -1, the dipole of which lies 
parallel to the all-trans hydrocarbon chains, was used to characterize 
the lipid acyl chain orientation (see [23] for details). 
2.4. Measurement of surface activity 
Surface properties of the lipid/peptide preparations were measured 
at 30°C with a Wilhelmy balance (Biegler, Vienna) equipped with a 
teflon trough (18 cm2), containing a 20 ml hypophase of 150 mM 
NaC1. DPPC, PG and palmitic acid (PA), 68:22:9 (by weight, [24]), 
were dissolved in chloroform/methanol 98:2 (v/v), and added to the 
dried polypeptide (lipid:polypeptide ratio 50:1, w/w). After sonica- 
tion, the solvents were evaporated under nitrogen and the residue 
was suspended by gentle ultrasonication (50 W, 48 kHz) in 150 mM 
NaCI at a lipid concentration of 10 mg/ml. 0.1 ml of the surfactant 
preparation was added as a droplet onto the hypophase and surface 
pressure was recorded continuously for 1 min. The presented values 
are the mean of three different recordings. 
3. Results 
3.1. Secondary structure of KL4 in phospholipid micelles and 
bilayers 
KL4 exhibits a high degree of t~-helical structure in DPC 
micelles with the CD spectrum exhibiting minima at 222 and 
208 nm, indicative of a-helical secondary structure (Fig. 1). 
From the molar ellipticities at 222 and 208 nm [25] an ix- 
helical content of 80% is estimated. The FT IR  spectrum of 
KL4 in DPPC/PG 7:3 (w/w) bilayers shows a peak maximum 
at 1656 cm -1, in the spectral region associated with helical 
structure. Deconvolution and curve fitting between 1700 cm -1 
and 1600 cm -1 [8,12,23] yields 84% of a-helices for lipid-as- 
sociated KL4. KL4 is helical also in non-lipid environments; 
in trifluoroethanol it gives a CD spectrum which is similar to 
that obtained in DPC micelles, and FT IR  spectroscopy of 
KL4 alone, i.e. after it has been spread on the germanium 
plate from an organic solvent solution, also results in 84% 
helical content. Inspection of the spacing of the charged Lys 
side-chains and the nonpolar aliphatic Leu side-chains in he- 
lical KL4 (Fig. 2) reveals a mixed nonpolar/polar surface. This 
is in sharp contrast to the spatial separation of polar and 
nonpolar side-chains along an amphipathic helix. 
3.2. Orientation of KLa in a phospholipid bilayer 
The distribution of charged and aliphatic residues in ct-he- 
lical KL4 raised questions regarding its preferred orientation 
in a phospholipid bilayer. A transmembranous orientation 
was expected to produce unfavourable interactions between 
the charged lysine amino groups and the lipid acyl chains, 
while an orientation perpendicular to the lipid acyl chains, 
the preferred orientation of amphipathic helices, was expected 
to give adverse interactions between the leucines and the polar 
phospholipid head-groups and the surrounding aqueous 
phase. KL4 associated with DPPC/PG 7:3 (w/w) vesicles 
[15] was analyzed by FT IR  spectroscopy with 0 ° and 90 ° 
polarized incident light. The dichroic spectrum (9004) °) 
clearly shows that the amide I' band and the "/w(CH2) band 
are strongly 90 ° polarized from the positive deviations cen- 
tered at 1657 cm -1, in the helix region, and at 1200 cm -1, 
respectively (Fig. 3). These positive deviations reflect a prefer- 
ential perpendicular orientation of both these dipole transi- 
tions relative to the germanium surface. From the dichroic 
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Fig. 1. CD spectrum of KL4 in DPC micelles. The spectrum was re- 
corded with a 21 tiM solution of KL4 in 10 mM DPC/50 mM so- 
dium phosphate buffer, pH 6.0 at 22°C. 
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Fig. 2. Helical wheel presentation f the KL4 amino acid sequence. 
The view is along the helical axis. The lysine residues are circled 
and identified by their sequence location to emphasize their even 
distribution over the entire helical circumference. 
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best characterized as mixed nonpolar/polar. This helical pep- 
tide, in spite of a lack of an all-hydrophobic part, adopts a 
transmembranous orientation. This is in sharp contrast o the 
mechanism of action first proposed for SP-B and KL4 [15] 
which involves simultaneous interactions between the posi- 
tively charged lysine side-chains and phospholipid head- 
groups on the one hand and interactions between leucine 
side-chains and superficial parts of lipid acyl chains on the 
other. Such interactions are difficult to envision with the 
KL4 helical surface and orientation in a phospholipid bilayer 
now found, suggesting another mechanism of action for KL4 
in pulmonary phospholipids. 
The secondary structure and transmembranous orientation 
of KL4 prompts investigation of its spreading properties in a 
lipid mixture, since another transmembrane h lix (SP-C/BR) 
with a primary structure which is unrelated to any of the 
pulmonary surfactant proteins has significant effects on lipid 
spreading kinetics [20,26]. KL4 does accelerate the spreading 
of lipids at an air/water interface but it is less effective than 
both native SP-C and the SP-C/BR hybrid in this respect. 
Perhaps the most prominent differences between KL4 on the 
one hand and native SP-C and SP-C/BR on the other are that 
(i) the KL4 helix is shorter (about 30 A, compared to 37,4, in 
native SP-C [13,14] and presumably also in SP-C/BR with the 
it is calculated that the helix axis and the all-trans lipid acyl 
chains make a maximum tilt from a normal to the ATR plate 
of 27 ° and 20 °, respectively. This means that the KL4 peptide 
is oriented practically parallel to the lipid acyl chains in a 
DPPC/PG bilayer. In other words, the approximately 30 A 
long KL4 peptide (assuming all-helical structure) is oriented in 
a transmembranous fa hion in the approximately 40,4, DPPC/ 
PG fluid bilayer. In this orientation only the centrally situated 
lysine (Lys-l l)  is forced to accomodate its charged amino 
group in an entirely nonpolar, hydrocarbon, environment 
since the amino groups of the remaining lysines with their 
side-chains directed towards the bilayer surface, will be able 
to interact with the phospholipid head-groups. Evidently, the 
single unfavourable interaction is compensated for by the 
many favourable interactions between aliphatic leucine side- 
chains and the lipid acyl chains. 
3.3. Effects of  KL4 on the spreading of  lipids at an air~water 
interface 
Spreading kinetics of 2% (w/w) of KL4 in a DPPC/PG/PA 
68:22:9 (by weight) mixture at an air/water interface was 
compared to that of native SP-C and SP-C/BR [20], both 
with transmembranous c~-helices in similar phospholipid mix- 
tures [11,12,14,26]. KL4 is less efficient han native SP-C and 
SP-C/BR in accelerating the spreading of the lipid mixture 
and also reaches a lower surface pressure after 1 min (Fig. 
4). Thus, a transmembranous a-helix as such is apparently not 
sufficient o give optimal spreading properties of lipid/peptide 
mixtures. 
4. Discussion 
KL4, with helix-promoting [27,28] leucine and lysine resi- 
dues only, exhibits a helical secondary structure in phospho- 
lipid micelles and bilayers. The helix presents a regular surface 
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Fig. 3. Dichroic spectrum of deuterated KL4 in oriented DPPC/PG 
7:3 (w/w) bilayers. The dichroic spectrum (top tracing) represents 
the difference between the spectra recorded with 90 ° and 0 ° polar- 
ized light. The recorded spectra re drawn with identical ordinate 
scale; the dichroic spectrum is expanded threefold in the ordinate 
direction. The arrows indicate the protein amide I' band at 1657 
cm -1 and the phospholipid yw(CH2) band at 1200 cm -1. The sam- 
ple was deuterated for 30 min. 
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Fig. 4. Spreading kinetics of KL4. Plots of surface pressure versus 
time with 2% (w/w) of KL4 (O), SP-C/BR (zx), or native SP-C (O) 
in DPPC/PG/PA 68:22:9 (by weight) compared to the lipids alone 
(m). 
same number of residues and similar a-helical content as na- 
tive SP-C [20]) and (ii) KL4 has a symmetric distribution of 
positively charged residues along the helix while native SP-C 
and SP-C/BR have basic residues exclusively at the N-terminal 
end of the helix. The latter may give KL4 a more static and 
uniform interaction with a phospholipid bilayer compared to 
native SP-C and SP-C/BR which both are expected to exhibit 
a 'mobility gradient' [14] due to greater lateral mobility in the 
C-terminal end than in the N-terminal end. We speculate that 
such effects may contribute to the observed differences in 
spreading kinetics between KL4 and native SP-C and SP-C/ 
BR. 
In summary, we have shown that the 21-residue peptide 
KL4 is a transmembranous helix with a mixed polar/nonpolar 
surface. The helix is oriented parallel to the lipid acyl chains 
and the structure and orientation of KL4 indicate that its 
mechanism of action is similar to that of SP-C, in contrast 
to previous suggestions [15-18]. This knowledge is useful for 
designing peptide analogues for further studies of the mechan- 
ism of action of pulmonary surfactant polypeptides. 
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